伊塔康酸:免疫反应和炎症代谢的调节剂
Kai Ma1, Pei Zhou1, Wei Zhang1
1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Current issues in molecular biology
|July 29, 2025
概括
伊塔科尼酸是一种抗炎化合物,调节免疫细胞和新陈代谢. 需要进一步的研究来探索其对炎症和代谢疾病的治疗潜力.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 伊塔康酸是一种二碳酸,具有已知的抗炎,抗氧化和抗瘤特性.
- 它是酸的衍生物,与三碳酸循环有关.
- 它在调节细胞代谢和免疫反应方面发挥作用.
研究的目的:
- 审查伊塔科纳酸在免疫调节和炎症代谢中的多样性作用.
- 阐明伊塔科纳特施加其作用的机制.
- 探索 itaconic 酸及其衍生物的治疗潜力.
主要方法:
- 关于itaconate生物功能研究的文献综述.
- 分析伊塔科纳酸对巨细胞和T/B细胞功能的影响.
- 研究伊塔科纳酸对炎症代谢途径的影响.
主要成果:
- 伊塔科纳特通过代谢重编程,极化,细胞因子抑制和氧化应激调节来调节巨细胞的功能.
- 它影响T细胞和B细胞的活动.
- 它调节炎症因子的产生,抑制糖酸脱酶,并影响细胞能量和脂质代谢.
结论:
- 伊塔康酸及其衍生物显示出显著的抗炎和抗氧化作用.
- 潜在的临床应用包括治疗炎症性疾病,癌症和微生物感染.
- 需要进一步的研究来评估长期的安全性,并扩大慢性炎症和代谢疾病的治疗策略.
相关概念视频
Inflammatory Response
7.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.5K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
Inflammatory Response I: Vascular and Cellular
12.5K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193


